Official data from INPI

122020014643

ArquivadaUtility ModelPCT · US2017055660

Talk to an expert

Application data

Number

122020014643

Type

Utility Model

Filing

10/06/2017

Publication

PCT

US2017055660

View on INPI

Progress at the INPI

Filing10/06/17
Publication
Abandoned
Allowance
Grant
In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/26/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ORIC PHARMACEUTICALS, INC.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

07/26/2022

RPI 2690

Exigência - art. 36 da LPI

#6.1

04/12/2022

RPI 2675

Conhecimento de parecer técnico

#7.1

12/14/2021

RPI 2658

Adição na publicação

#15.35

10/05/2021

RPI 2648

Notificação de pedido dividido

#2.4

10/27/2020

RPI 2599

Requerimento de pedido de patente

#2.10

Número de Protocolo '870200089283' em 17/07/2020 16:21 (WB)

07/28/2020

RPI 2586

From the same holder

112026002511 112025023844 SAIS DE MALONATO E GLICOLATO DE UM INIBIDOR DE EGFR FORMAS FÍSICAS DE UM INIBIDOR DE PRC2 FORMAS FARMACÊUTICAS DE UM INIBIDOR DE CD73 INIBIDORES DE QUINASE DO TIPO POLO 4, COMPOSIÇÃ FARMACÊUTICA COMPREENDENDO OS MESMOS E USO RELACIONADO COMPOSTOS INIBIDORES DE CD73, COMPOSIÇÃO FARMACÊUTICA QUE OS COMPREENDE, MÉTODO DE INIBIÇÃO DE CD73 IN VITRO E USO DOS REFERIDOS COMPOSTOS COMPOSTOS INIBIDORES DE CD73, COMPOSIÇÃO FARMACÊUTICA QUE OS COMPREENDE, MÉTODO DE INIBIÇÃO DE CD73 IN VITRO E USO DOS REFERIDOS COMPOSTOS

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.